Search Results 181-190 of 18728 for detox protocol

  1. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    Sponsor Protocol Number: MC1588. About this study ... withdrawal are not acceptable methods of contraception) ... withdrawal are not acceptable methods of ...

  2. Depo-Provera (birth control shot) - Mayo Clinic

    ... Association · Refer a Patient · Businesses · Executive Health Program · International Business Collaborations · Facilities & Real Estate · Supplier Information ...

  3. A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Sponsor Protocol Number: C16010. About this study ... (Periodic abstinence [eg, calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not ...

  4. Lidocaine (injection route) - Side effects & uses - Mayo Clinic

    ... Alumni Association · Refer a Patient · Businesses · Executive Health Program · International Business Collaborations · Facilities & Real Estate · Supplier ...

  5. Prescription drug abuse - Diagnosis and treatment - Mayo Clinic

    Treatment may also require withdrawal, also called detoxification, addiction medicine and recovery support. ... An employee assistance program, which may offer ...

  6. Treating pain responsibly in the midst of an opioid epidemic - Mayo Clinic

    ... procedure and making sure we use nonopioid ... It happens when a patient has received opioids for approximately five days or more and develops withdrawal ...

  7. Nonalcoholic fatty liver disease - Diagnosis and treatment - Mayo Clinic

    If other tests show signs of MASH, or if your test results are unclear, your healthcare professional may suggest a liver biopsy. Liver biopsy is a procedure to ...

  8. Prevalence and Predictors of Spike Protein Antibodies in COVID-19 Vaccinated Individuals - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

    Sponsor Protocol Number: GO39775. About this study ... Periodic abstinence (e.g., calendar, ovulation, symptothermal, or post-ovulation methods) and withdrawal ...

  10. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

    Sponsor Protocol Number: MC1782. About this study ... withdrawal are not acceptable methods of contraception). ... withdrawal are not acceptable methods of ...